Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

sulfanilamide

×

Overview

What is AVC?

AVC is a preparation for vaginal administration for the treatment of infections and available in the following form:

AVC Cream

Each tube contains:

Sulfanilamide.............................................................................................15.0% in a water-miscible, non-staining base made from lactose, propylene glycol, stearic acid, diglycol stearate, methylparaben, propylparaben, trolamine, and water; buffered with lactic acid to an acid pH of approximately 4.3.

Sulfanilamide is an anti-infective agent. It is p-amino-benzenesulfonamide with the chemical structure:

Sulfanilamide occurs as a white odorless crystalline powder with a slightly bitter taste and sweet aftertaste. It is slightly soluble in water, alcohol, acetone, glycerin, propylene glycol, hydrochloric acid, and solutions of potassium and sodium hydroxide. It is practically insoluble in chloroform, ether, benzene, and petroleum ether.



What does AVC look like?



What are the available doses of AVC?

Sorry No records found.

What should I talk to my health care provider before I take AVC?

Sorry No records found

How should I use AVC?

For the treatment of vulvovaginitis caused by . (See .)

One applicatorful (about 6 g) intravaginally once or twice daily. Improvements in symptoms should occur within a few days, but treatment should be continued for a period of 30 days.

Douching with a suitable solution before insertion may be recommended for hygienic purposes.


What interacts with AVC?

AVC should not be used in patients known to be sensitive to this product or to the sulfonamides.



What are the warnings of AVC?

Sorry No Records found


What are the precautions of AVC?

General

Because sulfonamides are absorbed from the vaginal mucosa, the usual precautions for oral sulfonamides apply. Patients should be observed for skin rash or evidence of systemic toxicity, and if these develop, the medications should be discontinued.

Deaths associated with administration of oral sulfonamides have reportedly occurred from hypersensitivity reactions, agranulocytosis, aplastic anemia, and other blood dyscrasias.

Goiter production, diuresis, and hypoglycemia have reportedly occurred rarely in patients receiving oral sulfonamides. Cross-sensitivity may exist with these agents. Rats appear to be especially susceptible to the goitrogenic effects of sulfonamides, and long-term administration has reportedly produced thyroid malignancies in this species.

Vaginal applicators or inserters should be used with caution after the seventh month of pregnancy.

Information For Patients

The doctor should advise the patient that in the event unusual local itching and burning occur, or other unusual symptoms develop, medication should be discontinued and not restarted without further consultation.

Drug Interactions

Drug interactions have not been documented with AVC.

Carcinogenesis, Mutagenesis, Impairment of Fertility

No data are available on long-term potential of AVC for carcinogenicity, mutagenicity, or impairment of fertility in animals or humans.

Pregnancy



Nursing Mothers

Sulfanilamide should be avoided in nursing mothers because absorbed sulfonamides will appear in maternal milk and have caused kernicterus in the newborn. Because of the potential for serious adverse reactions in nursing infants from sulfonamides, a decision should be made whether to discontinue nursing or to discontinue the drug.

Pediatric Use

Safety and effectiveness of AVC in pediatric patients have not been established.


What are the side effects of AVC?

Sorry No records found


What should I look out for while using AVC?

AVC should not be used in patients known to be sensitive to this product or to the sulfonamides.


What might happen if I take too much AVC?

There have been no reports of accidental overdosage with AVC.

The acute oral LD of sulfanilamide is 3700-4200 mg/kg in mice.

The minimum human lethal dose of AVC has not been established.

It is not known if AVC is dialyzable.


How should I store and handle AVC?

After Reconstitution with Bacteriostatic Water for Injection, USP (0.9% Benzyl Alcohol): The reconstituted solution should be stored under refrigeration (2 to 8°C/36 to 46°F) for no more than 14 days. Avoid freezing reconstituted vials of Zorbtive.AVC CreamNDC 0037-6631-04 4 oz tube with applicatorStore at room temperature, below 86°F.Protect from cold.Product darkens with age. Potency is maintained throughout labeled shelf life when stored as directed.This leaflet provides a summary of the important information about AVC Cream. You can get more information by calling the toll free number (1-877-999-8403).Distributed by:Meda PharmaceuticalsSomerset, New Jersey 08873-4120©2014 Meda Pharmaceuticals Inc.MEDA PHARMACEUTICALS and AVC are registered trademarks of Meda AB or a related entity.129941IN-663103-01Rev. 1/2014AVC CreamNDC 0037-6631-04 4 oz tube with applicatorStore at room temperature, below 86°F.Protect from cold.Product darkens with age. Potency is maintained throughout labeled shelf life when stored as directed.This leaflet provides a summary of the important information about AVC Cream. You can get more information by calling the toll free number (1-877-999-8403).Distributed by:Meda PharmaceuticalsSomerset, New Jersey 08873-4120©2014 Meda Pharmaceuticals Inc.MEDA PHARMACEUTICALS and AVC are registered trademarks of Meda AB or a related entity.129941IN-663103-01Rev. 1/2014AVC CreamNDC 0037-6631-04 4 oz tube with applicatorStore at room temperature, below 86°F.Protect from cold.Product darkens with age. Potency is maintained throughout labeled shelf life when stored as directed.This leaflet provides a summary of the important information about AVC Cream. You can get more information by calling the toll free number (1-877-999-8403).Distributed by:Meda PharmaceuticalsSomerset, New Jersey 08873-4120©2014 Meda Pharmaceuticals Inc.MEDA PHARMACEUTICALS and AVC are registered trademarks of Meda AB or a related entity.129941IN-663103-01Rev. 1/2014AVC CreamNDC 0037-6631-04 4 oz tube with applicatorStore at room temperature, below 86°F.Protect from cold.Product darkens with age. Potency is maintained throughout labeled shelf life when stored as directed.This leaflet provides a summary of the important information about AVC Cream. You can get more information by calling the toll free number (1-877-999-8403).Distributed by:Meda PharmaceuticalsSomerset, New Jersey 08873-4120©2014 Meda Pharmaceuticals Inc.MEDA PHARMACEUTICALS and AVC are registered trademarks of Meda AB or a related entity.129941IN-663103-01Rev. 1/2014AVC CreamNDC 0037-6631-04 4 oz tube with applicatorStore at room temperature, below 86°F.Protect from cold.Product darkens with age. Potency is maintained throughout labeled shelf life when stored as directed.This leaflet provides a summary of the important information about AVC Cream. You can get more information by calling the toll free number (1-877-999-8403).Distributed by:Meda PharmaceuticalsSomerset, New Jersey 08873-4120©2014 Meda Pharmaceuticals Inc.MEDA PHARMACEUTICALS and AVC are registered trademarks of Meda AB or a related entity.129941IN-663103-01Rev. 1/2014AVC CreamNDC 0037-6631-04 4 oz tube with applicatorStore at room temperature, below 86°F.Protect from cold.Product darkens with age. Potency is maintained throughout labeled shelf life when stored as directed.This leaflet provides a summary of the important information about AVC Cream. You can get more information by calling the toll free number (1-877-999-8403).Distributed by:Meda PharmaceuticalsSomerset, New Jersey 08873-4120©2014 Meda Pharmaceuticals Inc.MEDA PHARMACEUTICALS and AVC are registered trademarks of Meda AB or a related entity.129941IN-663103-01Rev. 1/2014AVC CreamNDC 0037-6631-04 4 oz tube with applicatorStore at room temperature, below 86°F.Protect from cold.Product darkens with age. Potency is maintained throughout labeled shelf life when stored as directed.This leaflet provides a summary of the important information about AVC Cream. You can get more information by calling the toll free number (1-877-999-8403).Distributed by:Meda PharmaceuticalsSomerset, New Jersey 08873-4120©2014 Meda Pharmaceuticals Inc.MEDA PHARMACEUTICALS and AVC are registered trademarks of Meda AB or a related entity.129941IN-663103-01Rev. 1/2014AVC CreamNDC 0037-6631-04 4 oz tube with applicatorStore at room temperature, below 86°F.Protect from cold.Product darkens with age. Potency is maintained throughout labeled shelf life when stored as directed.This leaflet provides a summary of the important information about AVC Cream. You can get more information by calling the toll free number (1-877-999-8403).Distributed by:Meda PharmaceuticalsSomerset, New Jersey 08873-4120©2014 Meda Pharmaceuticals Inc.MEDA PHARMACEUTICALS and AVC are registered trademarks of Meda AB or a related entity.129941IN-663103-01Rev. 1/2014AVC CreamNDC 0037-6631-04 4 oz tube with applicatorStore at room temperature, below 86°F.Protect from cold.Product darkens with age. Potency is maintained throughout labeled shelf life when stored as directed.This leaflet provides a summary of the important information about AVC Cream. You can get more information by calling the toll free number (1-877-999-8403).Distributed by:Meda PharmaceuticalsSomerset, New Jersey 08873-4120©2014 Meda Pharmaceuticals Inc.MEDA PHARMACEUTICALS and AVC are registered trademarks of Meda AB or a related entity.129941IN-663103-01Rev. 1/2014AVC CreamNDC 0037-6631-04 4 oz tube with applicatorStore at room temperature, below 86°F.Protect from cold.Product darkens with age. Potency is maintained throughout labeled shelf life when stored as directed.This leaflet provides a summary of the important information about AVC Cream. You can get more information by calling the toll free number (1-877-999-8403).Distributed by:Meda PharmaceuticalsSomerset, New Jersey 08873-4120©2014 Meda Pharmaceuticals Inc.MEDA PHARMACEUTICALS and AVC are registered trademarks of Meda AB or a related entity.129941IN-663103-01Rev. 1/2014AVC CreamNDC 0037-6631-04 4 oz tube with applicatorStore at room temperature, below 86°F.Protect from cold.Product darkens with age. Potency is maintained throughout labeled shelf life when stored as directed.This leaflet provides a summary of the important information about AVC Cream. You can get more information by calling the toll free number (1-877-999-8403).Distributed by:Meda PharmaceuticalsSomerset, New Jersey 08873-4120©2014 Meda Pharmaceuticals Inc.MEDA PHARMACEUTICALS and AVC are registered trademarks of Meda AB or a related entity.129941IN-663103-01Rev. 1/2014


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Sulfanilamide has been a useful ingredient of vaginal formulations for about four decades. It blocks certain metabolic processes essential for the growth of susceptible bacteria. In AVC, the sulfanilamide is in a specially compounded base buffered to the pH (about 4.3) of the normal vagina to encourage the presence of the normally occurring Döderlein’s bacilli of the vagina.

The use of AVC for the treatment of vulvovaginitis caused by is supported by three clinical investigations. The three studies show AVC with sulfanilamide to be significantly more effective (p ≤ 0.01) than placebo as follows:

In Study I, the ratio of effectiveness was 71% for the AVC with sulfanilamide versus 49% for placebo with 30 days of treatment;

In Study II, the percentages were 48% and 24%, respectively, with 15 days of treatment;

In Study III, the percentages were 66% versus 33%, respectively, with 30 days of treatment.

Non-Clinical Toxicology
AVC should not be used in patients known to be sensitive to this product or to the sulfonamides.

As with other drugs, the potential for interaction by a variety of mechanisms (e.g., pharmacodynamic, pharmacokinetic inhibition or enhancement, etc.) is a possibility (see

Because sulfonamides are absorbed from the vaginal mucosa, the usual precautions for oral sulfonamides apply. Patients should be observed for skin rash or evidence of systemic toxicity, and if these develop, the medications should be discontinued.

Deaths associated with administration of oral sulfonamides have reportedly occurred from hypersensitivity reactions, agranulocytosis, aplastic anemia, and other blood dyscrasias.

Goiter production, diuresis, and hypoglycemia have reportedly occurred rarely in patients receiving oral sulfonamides. Cross-sensitivity may exist with these agents. Rats appear to be especially susceptible to the goitrogenic effects of sulfonamides, and long-term administration has reportedly produced thyroid malignancies in this species.

Vaginal applicators or inserters should be used with caution after the seventh month of pregnancy.

To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc. at 1-877-999-8403 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

ADVERSE REACTIONS

Local sensitivity reactions such as increased discomfort or a burning sensation have occasionally been reported following the use of topical sulfonamides. With the use of AVC Cream, sensitivity reactions (only local) were reported for 0.2% of the investigational patients.

Treatment should be discontinued if either local or systemic manifestations of sulfonamide toxicity or sensitivity occur.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

This medication has worked for me.




This medication has been easy for me to use.




Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).